Poster Presentation Royal Australian Chemical Institute National Congress 2026

Covalent modulators of PPARγ: towards a new targeted cancer therapy (#623)

Jasmine L King 1 , W. Joost Lesterhuis 2 3 , Matthew J Piggott 1 2
  1. University of Western Australia, Perth, WA, Australia
  2. Setonix Pharmaceuticals, Perth, WA, Australia
  3. The Kids Institute Australia, Perth, WA, Australia
Publish consent withheld
  1. Bensinger, S. J.; Tontonoz, P. Nature 2008, 454 (7203), 470-477.
  2. Rochel, N., et al. Nat. Commun. 2019, 10, 253.
  3. Galbraith, L. C. A., et al. Oncogene 2021, 40 (13), 2355-2366.
  4. Goldstein, J. T., et al. Cancer Res. 2017, 77 (24), 6987-6998.
  5. Leesnitzer, L. M., et al. Biochemistry 2002, 41 (21), 6640-6650.
  6. Lee, G., et al. J. Biol. Chem. 2002, 277 (22), 19649-19657.
  7. King, J. L., et al. J. Med. Chem. 2025, 68 (22), 23705–23750.
  8. Sims, R., et al. Cancer Res. 2023, 83 (7_Supplement), ND08-ND08.
  9. King, J. L., et al. WO2024211969, Oct 17, 2024.